Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang

BACKGROUND: Qiangji Jianli Fang (QJF) has been used for treatment of myasthenia gravis (MG) in China. However, our understanding of the effects of QJF against MG at the molecular level is limited. This study aims to investigate the effects of QJF treatment of MG patients on the protein, peptide and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chunmei, Lu, Yonghai, Chen, Zhixi, Liu, Xiaobin, Lin, Huangquan, Zhao, Hui, Chen, Jinyan, Kwan, Yiuwa, Ngai, Saiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464942/
https://www.ncbi.nlm.nih.gov/pubmed/22838635
http://dx.doi.org/10.1186/1749-8546-7-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464942/
https://www.ncbi.nlm.nih.gov/pubmed/22838635
http://dx.doi.org/10.1186/1749-8546-7-16

Ejemplares similares